Drug intelligence / Profile preview

Appeon

Development stage: Unknown
Lead developer: Alico Pharmaceutical
Administration: Oral

Overview

Appeon, also known as Appatizer, is a nutraceutical dietary supplement developed and marketed by Alico Pharmaceutical. It is positioned as an appetite stimulant within the company's consumer retail product catalog. As a nutraceutical, it is not classified as a clinical-stage pharmaceutical drug and does not have specific molecular targets or clinical trial phases associated with it in the provided company documentation. It is intended for oral administration to support nutritional health and stimulate appetite in consumers.

Brand names: AppeonAppatizer
Other names: Appatizer

Beyond the preview

Go deeper on Appeon.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Appeon.

Explore the full profile